换一批
换一批Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.
作者：
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);衰老(Aging);临床试验, Ⅰ期(主题)(Clinical Trials, Phase I as Topic);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);糖尿病, 2型(Diabetes Mellitus, Type 2);双盲法(Double-Blind Method);女(雌)性(Female);半衰期(Half-Life);人类(Humans);高血糖症(Hyperglycemia);降血糖药(Hypoglycemic Agents);男(雄)性(Male);中年人(Middle Aged);肽类(Peptides);随机对照试验(主题)(Randomized Controlled Trials as Topic);受体, 胰高血糖素(Receptors, Glucagon)
DOI
10.1002/dmrr.2588
PMID
25115916
发布时间
2024-12-19
- 浏览34
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
